NCT00430924View on ClinicalTrials.gov

Inhibition of Aldosterone in Patients With Chronic Renal Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Eplerenone

Once daily administration for 8 weeks and 8 weeks control.

Trial Locations (2)

DK-2100 Ø

Rigshospitalet, Blegdamsvej 9, Copenhagen

DK-2730

Herlev Hospital, Herlev

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Lene Boesby

OTHER

NCT00430924 - Inhibition of Aldosterone in Patients With Chronic Renal Disease | Biotech Hunter | Biotech Hunter